Headlines: Don’t Allow Serum Institute To Conduct Covavax Trial On Children, Says Govt Panel

An expert panel on Wednesday recommended against granting permission to Pune’s Serum Institute of India (SII) for conducting the phase 2/3 trial of Covid-19 vaccine Covovax on children aged between two to 17 years, sources said. The panel asked the pharmaceutical company to complete trials on adults first.

#Covavax #Novavax #SerumInstituteofIndia #Covishield #Covaxin #EU #FarmersProtest

Dear Readers,
As an independent media platform, we do not take advertisements from governments and corporate houses. It is you, our readers, who have supported us on our journey to do honest and unbiased journalism. Please contribute, so that we can continue to do the same in future.

Related posts